|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-1-18
|
|
pubmed:abstractText |
To compare the relative systemic dose potency and tolerability of inhaled formoterol and salbutamol and to describe elimination of formoterol, particularly any enantioselectivity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0031-6970
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
363-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11009043-Administration, Inhalation,
pubmed-meshheading:11009043-Adult,
pubmed-meshheading:11009043-Albuterol,
pubmed-meshheading:11009043-Asthma,
pubmed-meshheading:11009043-Blood Glucose,
pubmed-meshheading:11009043-Blood Pressure,
pubmed-meshheading:11009043-Bronchodilator Agents,
pubmed-meshheading:11009043-Cross-Over Studies,
pubmed-meshheading:11009043-Dose-Response Relationship, Drug,
pubmed-meshheading:11009043-Double-Blind Method,
pubmed-meshheading:11009043-Drug Tolerance,
pubmed-meshheading:11009043-Ethanolamines,
pubmed-meshheading:11009043-Half-Life,
pubmed-meshheading:11009043-Humans,
pubmed-meshheading:11009043-Lactates,
pubmed-meshheading:11009043-Middle Aged,
pubmed-meshheading:11009043-Potassium
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
|
|
pubmed:affiliation |
Experimental Medicine, AstraZeneca R&D Lund, Sweden. Johan.Rosenborg@astrazeneca.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
